We are live on ! Find out more
MPA

Marvin & Palmer Associates Portfolio holdings

AUM $159M
1-Year Est. Return 109.02%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+109.02%
3 Year Est. Return
+392.2%
5 Year Est. Return
+719.89%
10 Year Est. Return
+4,985%
AUM
$97.6M
AUM Growth
+$13.9M
Cap. Flow
+$8.01M
Cap. Flow %
8.21%
Top 10 Hldgs %
38.42%
Holding
57
New
8
Increased
4
Reduced
35
Closed
7

Top Buys

Rank Stock Value
1
FN icon
Fabrinet
FN
+$4.85M
2
VNM icon
VanEck Vietnam ETF
VNM
+$2.59M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.56M
4
RTN
Raytheon Company
RTN
+$2.38M
5
V icon
Visa
V
+$1.79M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.94M
2
LRCX icon
Lam Research
LRCX
+$1.88M
3
CVS icon
CVS Health
CVS
+$1.52M
4
MCK icon
McKesson
MCK
+$1.51M
5
CMI icon
Cummins
CMI
+$946K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.21%
2 Technology 19.52%
3 Financials 18.72%
4 Industrials 10.23%
5 Healthcare 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAP icon
51
Credicorp
BAP
$30.7B
– –
-1,600
Closed -$170K
CVS icon
52
CVS Health
CVS
$122B
– –
-15,775
Closed -$1.52M
GOOG icon
53
Alphabet (Google) Class C
GOOG
$4.32T
– –
-18,000
Closed -$575K
LRCX icon
54
Lam Research
LRCX
$390B
– –
-288,000
Closed -$1.88M
MCK icon
55
McKesson
MCK
$101B
– –
-8,175
Closed -$1.51M
NXPI icon
56
NXP Semiconductors
NXPI
$60.4B
– –
-900
Closed -$78K
ALXN
57
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-12,400
Closed -$1.94M
1 2
3

Similar funds

RP
RIHO Partners Tucson, Arizona $159M AUM
SA
swisspartners Advisors Zurich, Switzerland $159M AUM 36.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BDAM
Blue Door Asset Management Stamford, Connecticut $159M AUM 38.2% 1-Year Est. Return
OC
Oppenheimer & Close New York $159M AUM 60.56% 1-Year Est. Return
JF
Jericho Financial Westerville, Ohio $159M AUM 27.21% 1-Year Est. Return
1L
10Elms LLP Tulsa, Oklahoma $159M AUM 13.16% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM

Marvin & Palmer Associates's Q4 2015 Portfolio in Review

As of Q4 2015, Marvin & Palmer Associates held 57 positions worth $97.6M, up 17% from $83.7M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Marvin & Palmer Associates deployed $8.01M of net new capital in Q4 2015, opening 8 new positions and adding to 4 existing holdings. Its largest new stake was Fabrinet: 217,700 shares worth $5.18M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cummins, an estimated $946K trimmed.

  • Marvin & Palmer Associates's largest Q4 2015 buy was Fabrinet: 217,700 shares worth $5.18M.
  • Marvin & Palmer Associates added most to VanEck Vietnam ETF in Q4 2015, an estimated $2.59M increase.
  • Marvin & Palmer Associates's biggest Q4 2015 reduction was Cummins, cutting an estimated $946K.
  • Marvin & Palmer Associates fully exited Alexion Pharmaceuticals in Q4 2015, selling an estimated $1.94M.
  • Marvin & Palmer Associates's ten largest holdings make up 38% of its $97.6M portfolio in Q4 2015.
  • Marvin & Palmer Associates opened 8 new positions and closed 7 in Q4 2015.
  • Marvin & Palmer Associates's portfolio value rose 17% quarter-over-quarter to $97.6M.

Based on Marvin & Palmer Associates's 13F filing for Q4 2015, filed 11 Feb 2016.